Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Do cortical lesions help us to distinguish MS from NMO?
Letter to the Editor.
Glycans of myelin proteins.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
Afferent visual pathways in multiple sclerosis: a review.
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients.
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
[Anti-NMDA receptor encephalitis - case report].
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Balo's Concentric Sclerosis with Acute Presentation and Co-Existing Multiple Sclerosis-Typical Lesions on MRI.
Neuroprotection With Phenytoin in Optic Neuritis
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.

Pages